210 related articles for article (PubMed ID: 2164093)
1. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey.
Dykstra LA
J Pharmacol Exp Ther; 1990 Jul; 254(1):245-52. PubMed ID: 2164093
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
Dykstra LA; Massie CA
J Pharmacol Exp Ther; 1988 Sep; 246(3):813-21. PubMed ID: 2843630
[TBL] [Abstract][Full Text] [Related]
3. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
[TBL] [Abstract][Full Text] [Related]
4. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation.
Oliveto AH; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Apr; 257(1):8-18. PubMed ID: 1850479
[TBL] [Abstract][Full Text] [Related]
7. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
Bergman J; Warren PH
J Pharmacol Exp Ther; 1989 Mar; 248(3):1102-8. PubMed ID: 2539457
[TBL] [Abstract][Full Text] [Related]
8. Agonist and antagonist activity of kappa opioids in the squirrel monkey: II. Effect of chronic morphine treatment.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1992 Jan; 260(1):334-42. PubMed ID: 1309877
[TBL] [Abstract][Full Text] [Related]
9. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
Walker EA; Young AM
J Pharmacol Exp Ther; 1993 Oct; 267(1):322-30. PubMed ID: 8229759
[TBL] [Abstract][Full Text] [Related]
10. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
Zimmerman DM; Leander JD; Reel JK; Hynes MD
J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
[TBL] [Abstract][Full Text] [Related]
11. The role of serotonin in the effects of opioids in squirrel monkeys responding under a titration procedure: I. Kappa opioids.
Powell KR; Dykstra LA
J Pharmacol Exp Ther; 1995 Sep; 274(3):1305-16. PubMed ID: 7562503
[TBL] [Abstract][Full Text] [Related]
12. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
Negus SS; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1991 Jan; 256(1):149-58. PubMed ID: 1846412
[TBL] [Abstract][Full Text] [Related]
13. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
Negus SS; Mello NK
Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
[TBL] [Abstract][Full Text] [Related]
14. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
Pitts RC; Allen RM; Walker EA; Dykstra LA
J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
[TBL] [Abstract][Full Text] [Related]
15. The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
Morgan D; Picker MJ
Psychopharmacology (Berl); 1998 Nov; 140(1):20-8. PubMed ID: 9862398
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure.
Dykstra LA; Granger AL; Allen RM; Zhang X; Rice KC
Psychopharmacology (Berl); 2002 Oct; 163(3-4):420-9. PubMed ID: 12373443
[TBL] [Abstract][Full Text] [Related]
17. A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.
Dykstra LA; Schoenbaum GM; Yarbrough J; McNutt R; Chang KJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):875-82. PubMed ID: 8246162
[TBL] [Abstract][Full Text] [Related]
18. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
Negus SS; Mello NK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
[TBL] [Abstract][Full Text] [Related]
20. Kappa antagonist properties of buprenorphine in the shock titration procedure.
Negus SS; Dykstra LA
Eur J Pharmacol; 1988 Oct; 156(1):77-86. PubMed ID: 2850212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
